Researchers find coupling of proteins promotes glioblastoma development

Previously unknown role of FoxM1 is crucial to regulation of brain tumor stem cells

2011-10-22

(Press-News.org) Two previously unassociated proteins known to be overly active in a variety of cancers bind together to ignite and sustain malignant brain tumors, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports this week in the journal Cancer Cell.

This research is the first to connect FoxM1 to a molecular signaling cascade that regulates normal neural stem cells, said senior author, Suyun Huang, M.D., Ph.D., associate professor in MD Anderson's Department of Neurosurgery.

"When FoxM1 binds to beta-catenin, we found that it also supports the self-renewal and differentiation of glioma- initiating cells, cancer stem cells thought to drive glioblastoma multiforme," Huang said.

Glioblastoma multiforme is the most common and lethal form of brain tumor. Glioma- initiating cells are prime suspects in the disease's resistance to treatment and ability to reoccur.

Protein's connection could be drug target

The scientists established the relationship between FoxM1 and beta-catenin in a series of cell line experiments and then confirmed their findings in mouse models of human glioblastoma and in an analysis of human tumors.

FoxM1 and beta-catenin separately so far have largely evaded targeting by drugs. Huang and her team are focusing on the details of the connection between the two proteins in search of small molecules that might block their binding.

"Our study might lead to the development of a new class of small-molecule anti-cancer drugs, including but not necessarily limited to glioblastoma multiforme," Huang said. Much preclinical work remains before such a drug can be identified and brought to clinical trial.

Blocking FoxM1 reduces glioblastoma in mice 100 percent

FoxM1 previously was known solely as a transcription factor – a protein that binds to the DNA in a gene's promoter region to prompt the gene's expression of messenger RNA that is processed into a protein.

Structural analysis led Huang and her team to suspect FoxM1 might be a binding match for beta-catenin, a crucial protein in the Wnt signaling pathway, which regulates self-renewal and differentiation of neural stem cells. When a normal cell divides, it produces two copies of itself. A neural stem cell produces one copy of itself (self-renewal) and a copy of a functional brain cell, such as a neuron or an astrocyte (differentiation). Mutations occur in the Wnt pathway in other types of cancer, but are largely absent in glioblastoma.

Blocking either FoxM1 or beta-catenin function strongly influenced whether mice injected with glioblastoma cells developed brain tumors. Most dramatically, blocking FoxM1 with short hairpin RNA completely prevented development of brain tumors in 38 mice, while all 20 with unimpeded FoxM1 developed tumors.

In a series of cell line experiments leading to the mouse model research, the group found:

FoxM1 is expressed at high levels in glioma and in glioma-initiating cells. FoxM1 and beta-catenin bind to each other in tumor cells. Wnt promotes the movement of both FoxM1 and beta-catenin to the cell nucleus. FoxM1 is required for beta-catenin to move to the cell nucleus in both neural stem cells and in tumor cells. The FoxM1 and beta-catenin connection is required for transcription and expression of beta-catenin Wnt- targeted genes in the nucleus. Interaction between the two proteins is critical to both cell renewal and differentiation in glioma stem cells. The team analyzed 40 glioblastoma samples and found FoxM1 moderately expressed in 14 and highly expressed in 18. Levels of FoxM1 in the cell nucleus correlated directly with levels of beta-catenin expression and the expression of two Wnt target genes.

Additional analysis of eight tumors found the two proteins present together in the cell nuclei and a direct correlation with the presence of one protein marker for glioma-initiating cells.

### Co-authors with Huang are first authors Nu Zhang, Ph.D., and Ping Wei, Ph.D., Aihua Gong, Ph.D., Wen-Tai Chiu, Ph.D, Hsueh-Te Lee, Ph. D, Jianfei Xue, Ph.D., Mingguang Liu, M.D., Yong Wang, Ph.D., and Raymond Sawaya, M.D. ,of MD Anderson's Department of Neurosurgery; Howard Colman, M.D., and W.K. Alfred Yung, M.D., of MD Anderson's Department of Neuro-Oncology. Keping Xie, M.D., Ph.D .,of MD Anderson's Department of Gastrointestinal Medical Oncology and the program in cancer biology at The University of Texas Graduate School of Biomedical Science at Houston; Rene Medema, M.D., of the Department of Medical Oncology, UMC Utrecht, Utrecht, The Netherlands; and Xi He, Ph.D., and He Huang, Ph.D., of the F.M. Kirby Neurobiology Center, Children's Hospital Boston and Harvard Medical School.

Artwork chosen by Cell Press for the cover of Cancer Cell was designed by Huang's daughter Victoria Xie, a sophomore at Michael DeBakey High School for Health Professions in Houston.

This research was funded by grants from the National Cancer Institute, the National Institute of General Medical Sciences, a multidisciplinary research grant by MD Anderson, and the Leukemia and Lymphoma Society.

About MD Anderson The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. MD Anderson is one of only 40 comprehensive cancer centers designated by the National Cancer Institute. For eight of the past 10 years, including 2011, MD Anderson has ranked No. 1 in cancer care in "Best Hospitals," a survey published annually in U.S. News & World Report.

Get MD Anderson News Via RSS Follow MD Anderson News on Twitter

ELSE PRESS RELEASES FROM THIS DATE:

Sixth Circuit Court Rules Definition of "Employee" Includes Some Volunteers, Extending Title VII Discrimination Protection

2011-10-22

by: Edward Macey A recent ruling from Sixth Circuit Court of Appeals specifically confirms that the federal civil rights laws protect certain volunteers from discrimination at work. The case brought by a volunteer firefighter against the Middlefield Fire Dept. was originally thrown out before trial by the lower court. The Appeals court ruling reverses the lower court and sends the discrimination case back for trial, based on a determination that the law's protection against discrimination and harassment for "employees" includes employees who are unpaid. The ...

Why do some athletes choke under pressure?

2011-10-22

Athletes know they should just do their thing on the 18th hole, or during the penalty shootout, or when they're taking a 3-point shot in the last moments of the game. But when that shot could mean winning or losing, it's easy to choke. A new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science, looks at why paying too much attention to what you're doing can ruin performance. "We think when you're under pressure, that your attention goes inward naturally. Suddenly it means so much, you want to make sure ...

Psychologists defend the importance of general abilities

2011-10-22

"What makes a great violinist, physicist, or crossword puzzle solver? Are experts born or made? The question has intrigued psychologists since psychology was born -- and the rest of us, too, who may secretly fantasize playing duets with Yo Yo Ma or winning a Nobel Prize in science. It's no wonder Malcolm Gladwell stayed atop the bestseller lists by popularizing the "10,000-hour rule" of Florida State University psychologist K. Anders Ericsson. Using Ericsson's pioneering work -- but omitting equally prominent, contradictory, research -- Gladwell's book Outliers argued that ...

Commonly used 3-drug regimen for idiopathic pulmonary fibrosis found harmful

2011-10-22

The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has stopped one arm of a three arm multi-center, clinical trial studying treatments for the lung-scarring disease idiopathic pulmonary fibrosis (IPF) for safety concerns. The trial found that people with IPF receiving a currently used triple-drug therapy consisting of prednisone, azathioprine, and N-acetylcysteine (NAC) had worse outcomes than those who received placebos, or inactive substances. "These findings underscore why treatments must be evaluated in a rigorous manner," ...

Trio of studies support use of PET/CT scans as prostate cancer staging tool

2011-10-22

ROCHESTER, Minn. -- Recent studies have suggested that C-11 choline positron emission tomography/computerized tomography (PET/CT) scans can be utilized as a staging and potentially therapeutic tool in prostate cancer. The results of three studies, released today during a meeting of the North Central Section of the American Urological Association (http://www.ncsaua.org/default.aspx), validate findings in Europe and expand the potential use of C-11 choline PET scans. One study found that C-11 choline PET/CT scans can be used as a staging tool rather than multiple x-rays, ...

Divorced Children Receive Less Financial Help From Their Parents

2011-10-22

A recent study conducted by Rice University reveals that children of divorced parents typically receive less college financial aid from their parents as compared with children of intact marriages. The study surveyed 2,400 undergraduate students and was published in SAGE Publications' June 2011 issue of its "Journal of Family Issues." The study examined whether divorced/separated and remarried parents contribute less in absolute dollars, as a proportion of their income, and as a proportion of their children's financial need, toward their children's college ...

Mayo Clinic study: PSA test valuable in predicting biopsy need, low-risk prostate cancer

2011-10-22

ROCHESTER, Minn. -- The prostate-specific antigen test, commonly known as the PSA test, is valuable in predicting which men should have biopsies and which are likely to be diagnosed with low-risk prostate cancer, a Mayo Clinic study has found. The findings were released today during a meeting of the North Central Section of the American Urological Association (http://www.ncsaua.org/default.aspx) in Rancho Mirage, Calif. "The decision to use the PSA test is best made by the patient, in consultation with his doctor," says R. Jeffrey Karnes, M.D. (http://www.mayoclinic.org/bio/12463493.html), ...

Study finds no correlation between primary kidney stone treatment and diabetes

2011-10-22

ROCHESTER, Minn. -- A Mayo Clinic study finds no correlation between the use of shock waves to break up kidney stones and the long-term development of diabetes. The study was released Friday during a meeting of the North Central Section of the American Urological Association (http://www.ncsaua.org/default.aspx) in Rancho Mirage, Calif. "We did not identify a significant correlation between shockwave lithotripsy and the long-term development of diabetes mellitus," says Matthew Gettman, M.D. (http://www.mayoclinic.org/bio/11940808.html), a Mayo Clinic urologist and co-author ...

November 2011 Geology highlights: New research posted Oct. 5

2011-10-22

Boulder, CO, USA - Another packed issue of GEOLOGY, The Geological Society of America's premier journal and the top-most cited geoscience journal in the world (http://www.scimagojr.com/journalrank.php?category=1907) is online in pre-issue publication. Topics include the San Andreas Fault and SAFOD; the 1944 Tonankai earthquake, Japan; Bonin Island beach sands; the fluid properties of ice; fracturing of the Panamanian Isthmus; diatoms from Ocean Drilling Program Site U1304; China's Loess Plateau; deglaciation and climate change in Turkey; an ancient Death Valley landslide; ...

Preventing cancer development inside the cell cycle

2011-10-22

Researchers from the NYU Cancer Institute, an NCI-designated cancer center at NYU Langone Medical Center, have identified a cell cycle-regulated mechanism behind the transformation of normal cells into cancerous cells. The study shows the significant role that protein networks can play in a cell leading to the development of cancer. The study results, published in the October 21 issue of the journal Molecular Cell, suggest that inhibition of the CK1 enzyme may be a new therapeutic target for the treatment of cancer cells formed as a result of a malfunction in the cell's ...

Researchers find coupling of proteins promotes glioblastoma development

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: